Setting out an ambitious strategy and ensuring it is implemented
The BIOASTER corporate governance consists of a Board of Directors and a Scientific Advisory Board.
Philippe Archinard – Président
Board of directors
LYONBIOPÔLE
Philippe ARCHINARD
Président
LYONBIOPÔLE
Florence AGOSTINO-ETCHETTO
INSTITUT PASTEUR
François ROMANEIX
BIOMÉRIEUX
François LACOSTE
BOEHRINGER INGELHEIM
Erick LELOUCHE
CNRS
Frédéric FAURE
CEA
Olivier PEYRET
DANONE
Gérard DENARIAZ
INSERM
Yazdan YAZDANPANAH
INSTITUT MÉRIEUX
Jean-Luc BELINGARD
SANOFI PASTEUR
Marie-José QUENTIN-MILLET
UNIVERSITÉ de LYON
Frédéric FLEURY
SME
Guy-Charles FANNEAU DE LA HORIE
SANOFI
Jacques VOLCKMANN
Phillippe LEISSNER
Olivier DUGRIP
Recteur de la région académique Auvergne-Rhône-Alpes, Chancelier des universités
LE MONDE VÉTÉRINAIRE
Emmanuelle SOUBEYRAN
LA METROPOLE DE LYON
David KIMELFELD
RÉGION AUVERGNE RHÔNE-ALPES
Laurent WAUQUIEZ
MEDICEN
En cours de nomination
Scientific advisory board
The board meets twice a year on BIOASTER premises.
Chairman: Dr Didier MAZEL (Institut Pasteur)
Pr Nicolas BARNICH
Professeur à l’université de Clermont Auvergne.
Directeur de l’unité mixte INSERM/UCA M2iSH
Dr Carole HEILMAN
Former NIAID , Vaccines Branch Director.
Member of the board of the TuBerculosis Vaccine Initiative (TBVI) network
Dr Marie-Paule KIENY
Ex Deputy CEO, WHO. DNDI Board of Directors.
Independant Director (member of the Board) of bioMérieux
Pr Jean-Luc MAINARDI
Service Microbiologie,
Hôpital Georges Pompidou, AP-HP
Dr. Claudine MEDIGUE
Head of LABGeM at Genoscope (CEA/CNRS)
Chairman of IFP Bioinfo
Dr. Annick MERCENIER
Ex Science & Strategy Coordinator, Nutrition & Health Research,
Nestlé Research Center, Lausanne
Pr. Marie-Cécile PLOY
Head of UMR 1092
(Inserm, University Hospital of Limoges)
Dr. Jean-Paul PRIELS
Board member of several biotechs and start-ups.
Former Senior VP R&D at GSK
Dr. Hélène TOUZET
Head of Bonsai team in CRIStAL lab (CNRS, Univ. de Lille)
Dr. Marcelle VAN MECHELEN
Senior Scientific Advisor in several biotech companies